Cancer Detection and Diagnosis Research
CFDA 93.394 · Federal Grants & Funding
Total Funding
$4.05B
Awards
2K
Recipients
417
States
45
Last Updated
Mar 20, 2026
Yearly Funding Trend
| Fiscal Year | Obligations | Awards | YoY Change |
|---|---|---|---|
| 2024 | $3.45B | 1K | |
| 2025 | $530.4M | 390 | -84.6% |
| 2026 | $72.0M | 44 | -86.4% |
Award Type Mix
| Type | Obligations | Awards |
|---|---|---|
| $0 | 0 |
Top 50 Awards under CFDA 93.394
Largest individual obligations for Cancer Detection and Diagnosis Research.
| Award | Recipient | Awarding Agency | Place | FY | Obligation |
|---|---|---|---|---|---|
ASST_NON_U24CA086368_075 THE EARLY DETECTION RESEARCH NETWORK: DATA MANAGEMENT AND COORDINATING CENTER - PROJECT SUMMARY THE KEY FOR THE EARLY DETECTION RESEARCH NETWORK (EDRN)'S SUCCESS LIES IN GOOD COMM… | FRED HUTCHINSON CANCER CENTER Washington | Department of Health and Human Services National Institutes of Health | SEATTLE, WA-07 | 2024 | $67,679,289 |
ASST_NON_U24CA196067_075 NRG ONCOLOGY BIOSPECIMEN BANK - PROJECT SUMMARY: NRG ONCOLOGY (HEREAFTER NRG), A MEMBER OF THE NCI-SUPPORTED NATIONAL CLINICAL TRIALS NETWORK (NCTN), WAS CREATED IN 2014 THROUGH T… | NRG ONCOLOGY FOUNDATION INC Pennsylvania | Department of Health and Human Services National Institutes of Health | PHILADELPHIA, PA-03 | 2024 | $38,139,324 |
ASST_NON_P01CA118816_075 IMAGING AND GENOMIC SIGNATURES OF BRAIN TUMOR HETEROGENEITY AND EVOLUTION TO OPTIMIZE PATIENT MANAGEMENT - OVERALL: PROJECT ABSTRACT THE OVERALL GOAL OF THIS RENEWAL P01 PROPOSAL… | REGENTS OF THE UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, THE California | Department of Health and Human Services National Institutes of Health | SAN FRANCISCO, CA-11 | 2024 | $37,222,203 |
ASST_NON_U24CA196172_075 ECOG-ACRIN BIOSPECIMEN BANK TO SUPPORT NCTN - PROJECT SUMMARY ECOG-ACRIN (EA) REPRESENTS THE MERGER OF ECOG AND ACRIN TO FORM A COOPERATIVE GROUP FOCUSED ON PRACTICE-CHANGING CLIN… | ECOG-ACRIN MEDICAL RESEARCH FOUNDATION, INC. Pennsylvania | Department of Health and Human Services National Institutes of Health | PHILADELPHIA, PA-03 | 2024 | $36,939,788 |
ASST_NON_U24CA196175_075 SWOG BIOSPECIMEN BANK TO SUPPORT NCI NCTN - PROJECT SUMMARY SWOG IS AN ADULT CLINICAL TRIALS CANCER GROUP WITHIN THE NATIONAL CLINICAL TRIALS NETWORK (NCTN) OF THE NATIONAL CANCER… | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL Ohio | Department of Health and Human Services National Institutes of Health | COLUMBUS, OH-03 | 2024 | $34,218,689 |
ASST_NON_U24CA196171_075 THE ALLIANCE NCTN BIOREPOSITORY AND BIOSPECIMEN RESOURCE - PROJECT SUMMARY/ABSTRACT THE NCTN'S ALLIANCE FOR CLINICAL TRIALS IN ONCOLOGY (ALLIANCE) AND ITS ASSOCIATED BIOREPOSITORI… | WASHINGTON UNIVERSITY, THE Missouri | Department of Health and Human Services National Institutes of Health | SAINT LOUIS, MO-01 | 2024 | $31,266,453 |
ASST_NON_UG1CA189854_075 GULF SOUTH CLINICAL TRIALS NETWORK (GULF SOUTH NCORP) - THE GULF SOUTH CLINICAL TRIALS NETWORK - NCORP (GULF SOUTH -NCORP) AND THE OCHSNER-COMMUNITY-NCORP, THE TWO NCORPS IN LOUIS… | LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER NEW ORLEANS Louisiana | Department of Health and Human Services National Institutes of Health | LA-90 | 2024 | $24,112,272 |
ASST_NON_P01CA210961_075 THE I SPY 2.2 TRIAL: EVOLVING TO IMAGING AND MOLECULAR BIOMARKER RESPONSE DIRECTED ADAPTIVE SEQUENTIAL TREATMENT TO OPTIMIZE BREAST CANCER OUTCOMES - THE I-SPY PROGRAM PROJECT ADV… | REGENTS OF THE UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, THE California | Department of Health and Human Services National Institutes of Health | SAN FRANCISCO, CA-11 | 2024 | $18,143,614 |
ASST_NON_U01CA086400_075 GREAT LAKES NEW ENGLAND CLINICAL VALIDATION CENTER - THE GREAT LAKES NEW ENGLAND CLINICAL VALIDATION CENTER (GLNE CVC), A CLINICAL VALIDATION CONSORTIUM COMPONENT OF THE EARLY DET… | THE UNIVERISTY OF TEXAS M.D. ANDERSON CANCER CENTER Texas | Department of Health and Human Services National Institutes of Health | TX-90 | 2024 | $16,667,828 |
ASST_NON_U24CA254445_075 (EET BIOBANK) NCI EARLY-PHASE AND EXPERIMENTAL CLINICAL TRIALS BIOSPECIMEN BANK - PROJECT SUMMARY THE BIOPATHOLOGY CENTER (BPC), PART OF THE ABIGAIL WEXNER RESEARCH INSTITUTE OF… | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL Ohio | Department of Health and Human Services National Institutes of Health | COLUMBUS, OH-03 | 2024 | $14,375,892 |
ASST_NON_U01CA152637_075 FRED HUTCHINSON BREAST CANCER CLINICAL VALIDATION CENTER - ABSTRACT THERE REMAIN CLEAR CLINICAL AND PUBLIC HEALTH NEEDS TO IMPROVE THE EARLY DETECTION OF BREAST CANCER. WHILE MAMM… | FRED HUTCHINSON CANCER CENTER Washington | Department of Health and Human Services National Institutes of Health | SEATTLE, WA-07 | 2024 | $13,581,230 |
ASST_NON_P01CA221775_075 PRECISION DELIVERY AND IMAGING TO ENHANCE SOLID TUMOR THERAPY - PROJECT 1 SUMMARY EXISTING ANTIBODY-BASED INTERVENTIONS FOR CANCER RELY ON PASSIVE DELIVERY OF THE CIRCULATING DRU… | PROTEOGENOMICS RESEARCH INSTITUTE FOR SYSTEMS MEDICINE California | Department of Health and Human Services National Institutes of Health | CA-90 | 2025 | $13,188,464 |
ASST_NON_U01CA113913_075 PROSTATE CANCER BIOMARKER AND IMAGING VALIDATION ALLIANCE: EMORY UNIVERSITY, UNIVERSITY OF ALABAMA BIRMINGHAM, AND UNIVERSITY OF TEXAS SOUTHWESTERN - WE HYPOTHESIZE THAT NEW BIOMA… | EMORY UNIVERSITY Georgia | Department of Health and Human Services National Institutes of Health | GA-90 | 2024 | $13,036,468 |
ASST_NON_U01CA152662_075 CLINICAL UTILITY OF A COMBINED BIOMARKER APPROACH TO DIAGNOSE LUNG CANCER - PROJECT SUMMARY LUNG CANCER REMAINS THE NUMBER ONE CANCER KILLER IN THE UNITED STATES AND CLINICALLY US… | VANDERBILT UNIVERSITY MEDICAL CENTER Tennessee | Department of Health and Human Services National Institutes of Health | NASHVILLE, TN-05 | 2024 | $12,769,066 |
ASST_NON_U2CCA233291_075 INTEGRATIVE SINGLE-CELL ATLAS OF HOST AND MICROENVIRONMENT IN COLORECTAL NEOPLASTIC TRANSFORMATION - PROJECT SUMMARY: OVERALL COLORECTAL CANCER (CRC) IS AMONG THE TOP THREE MOST P… | VANDERBILT UNIVERSITY MEDICAL CENTER Tennessee | Department of Health and Human Services National Institutes of Health | NASHVILLE, TN-07 | 2024 | $12,245,541 |
ASST_NON_U01CA210240_075 PANCREATIC CANCER DETECTION CONSORTIUM - ABSTRACT THIS PROPOSAL TO CONTINUE IN THE PANCREATIC CANCER DETECTION CONSORTIUM WILL FURTHER BUILD AND ENHANCE OUR BIOSPECIMEN RESOURCE T… | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA Nebraska | Department of Health and Human Services National Institutes of Health | NE-90 | 2024 | $12,073,999 |
ASST_NON_P01CA229997_075 ADAPTING MULTIPLE BEHAVIOR INTERVENTIONS THAT EFFECTIVELY IMPROVE (AMPLIFI) CANCER SURVIVOR HEALTH - ADAPTING MULTIPLE BEHAVIOR INTERVENTIONS THAT EFFECTIVELY IMPROVE (AMPLIFI) CA… | UNIVERSITY OF ALABAMA AT BIRMINGHAM Alabama | Department of Health and Human Services National Institutes of Health | BIRMINGHAM, AL-07 | 2025 | $11,803,149 |
ASST_NON_UM1CA183727_075 TENNESSEE VALLEY COOPERATIVE HUMAN TISSUE NETWORK - PROJECT SUMMARY THE COOPERATIVE HUMAN TISSUE NETWORK (CHTN) HAS PLAYED AN IMPORTANT ROLE SINCE 1987 AS A SOURCE OF HUMAN TISSU… | VANDERBILT UNIVERSITY MEDICAL CENTER Tennessee | Department of Health and Human Services National Institutes of Health | NASHVILLE, TN-05 | 2024 | $11,532,472 |
ASST_NON_U01CA200468_075 CLINICAL VALIDATION CENTER FOR EARLY DETECTION OF PANCREATIC CANCER - EARLY DETECTION OF PANCREATIC DUCTAL ADENOCARCINOMA (PDAC) IS AN AREA OF HIGHEST PRIORITY AND AN UNMET NEED F… | THE UNIVERISTY OF TEXAS M.D. ANDERSON CANCER CENTER Texas | Department of Health and Human Services National Institutes of Health | TX-90 | 2024 | $10,116,553 |
ASST_NON_U01CA200466_075 VALIDATION OF BIOMARKERS FOR RISK PREDICTION AND EARLY DIAGNOSIS OF PANCREATIC ADENOCARCINOMA - ABSTRACT PANCREATIC ADENOCARCINOMA (PDAC), WITH AN OVERALL 5-YEAR SURVIVAL OF 11%,… | UNIVERSITY OF PITTSBURGH - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION Pennsylvania | Department of Health and Human Services National Institutes of Health | PA-90 | 2024 | $10,031,963 |
ASST_NON_U54CA260560_075 VULNERABILITY OF SARS- COV-2 INFECTION IN LUNG CANCER BASED ON SEROLOGICAL ANTIBODY ANALYSES - PROJECT SUMMARY/ABSTRACT THE MOUNT SINAI U54 CONTINUES TO ACCRUE NEW LUNG CANCER (LC… | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI New York | Department of Health and Human Services National Institutes of Health | NY-90 | 2024 | $10,004,244 |
ASST_NON_R01CA237533_075 EXTENDING THE DIVERSITY, REACH, AND GENERALIZABILITY OF THE WISDOM STUDY - PROJECT SUMMARY/ABSTRACT THE WISDOM STUDY (WOMEN INFORMED TO SCREEN DEPENDING ON MEASURES OF RISK) IS A… | REGENTS OF THE UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, THE California | Department of Health and Human Services National Institutes of Health | CA-90 | 2024 | $9,088,649 |
ASST_NON_R01CA113941_075 TIME-OF-FLIGHT PET FOR IMPROVED WHOLE-BODY IMAGING - PROJECT SUMMARY THIS APPLICATION IS A COMPETITIVE RENEWAL OF R01-CA-113941 TO DEVELOP TECHNOLOGY AND METHODOLOGIES FOR TIME- O… | TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA, THE Pennsylvania | Department of Health and Human Services National Institutes of Health | PHILADELPHIA, PA-03 | 2024 | $8,756,375 |
ASST_NON_U01CA210170_075 USING MARKERS TO IMPROVE PANCREATIC CANCER SCREENING AND SURVEILLANCE: A MULTI-CENTER STUDY - ABSTRACT PATIENTS DIAGNOSED WITH STAGE I PANCREATIC CANCER HAVE A MUCH BETTER OUTCOME… | THE JOHNS HOPKINS UNIVERSITY Maryland | Department of Health and Human Services National Institutes of Health | MD-90 | 2024 | $8,639,610 |
ASST_NON_U01CA152990_075 PROTEOMIC, GENOMIC, AND LONGITUDINAL PATHWAYS TO OVARIAN CANCER BIOMARKER DISCOVERY - PROJECT SUMMARY THIS ADMINISTRATIVE SUPPLEMENT SEEKS SUPPORT FOR ADMINISTRATION OF THE UTERIN… | THE GENERAL HOSPITAL CORPORATION Massachusetts | Department of Health and Human Services National Institutes of Health | MA-90 | 2024 | $8,540,242 |
ASST_NON_U24CA215109_075 TCIA SUSTAINMENT AND SCALABILITY - PLATFORMS FOR QUANTITATIVE IMAGING INFORMATICS IN PRECISION MEDICINE - PROJECT SUMMARY THE NATIONAL RESEARCH COUNCIL HAS DEFINED PRECISION MEDIC… | UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES Arkansas | Department of Health and Human Services National Institutes of Health | LITTLE ROCK, AR-02 | 2024 | $8,264,991 |
ASST_NON_U01CA210138_075 MAYO CLINIC PROSPECTIVE RESOURCE FOR BIOMARKER VALIDATION AND EARLY DETECTION OF PANCREATIC CANCER - PANCREATIC DUCTAL ADENOCARCINOMA (PDAC) IS TYPICALLY DETECTED AT LATE STAGE DU… | MAYO CLINIC Minnesota | Department of Health and Human Services National Institutes of Health | MN-90 | 2024 | $8,248,315 |
ASST_NON_U01CA200462_075 MD ANDERSON CANCER CENTER EDRN- CLINICAL VALIDATION CENTER FOR EARLY DETECTION OF OVARIAN CANCER WITH A MULTIPLE MARKER ALGORITHM - ABSTRACT: ADVANCES IN CYTOREDUCTIVE SURGERY AND… | THE UNIVERISTY OF TEXAS M.D. ANDERSON CANCER CENTER Texas | Department of Health and Human Services National Institutes of Health | TX-90 | 2024 | $8,201,191 |
ASST_NON_R35CA232130_075 ANNOTATING CANCER BIOLOGY THROUGH NON-INVASIVE MOLECULAR IMAGING - ABSTRACT MOLECULAR IMAGING (MI) ORIGINATED IN THE NEED TO BETTER UNDERSTAND THE FUNDAMENTAL MOLECULAR PATHWAYS I… | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH New York | Department of Health and Human Services National Institutes of Health | NEW YORK, NY-12 | 2024 | $8,153,426 |
ASST_NON_U01CA233370_075 EFIRM LIQUID BIOPSY RESEARCH LABORATORY: EARLY LUNG CANCER ASSESSMENT - PROJECT SUMMARY/ABSTRACT: COMPUTED TOMOGRAPHY (CT) IS CURRENTLY THE MOST SENSITIVE TEST FOR DETECTING PREC… | UNIVERSITY OF CALIFORNIA, LOS ANGELES California | Department of Health and Human Services National Institutes of Health | LOS ANGELES, CA-36 | 2024 | $8,020,404 |
ASST_NON_U01CA214254_075 EXOSOME-BASED MICRORNA BIOMARKERS FOR NON-INVASIVE AND EARLY DETECTION OF PANCREATIC CANCER - PANCREATIC CANCER IS A HIGHLY AGGRESSIVE MALIGNANCY THAT IS ESTIMATED TO BECOME THE S… | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE California | Department of Health and Human Services National Institutes of Health | DUARTE, CA-31 | 2024 | $7,986,946 |
ASST_NON_U01CA200464_075 QUANTITATIVE IMAGING CLINICAL VALIDATION CENTER AT MOFFITT CANCER CENTER - PROJECT SUMMARY/ABSTRACT AN OVERARCHING GOAL OF CANCER SCREENING IS TO DETECT CANCER AT AN EARLY STAGE W… | H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE HOSPITAL, INC. Florida | Department of Health and Human Services National Institutes of Health | TAMPA, FL-15 | 2024 | $7,906,350 |
ASST_NON_U01CA176058_075 THE DANA-FARBER CANCER INSTITUTE CANCER TARGET DISCOVERY AND DEVELOPMENT CENTER - ABSTRACT INTERNATIONAL EFFORTS TO CHARACTERIZE CANCER GENOMES NOW PROVIDE US WITH AN INITIAL VIEW… | DANA-FARBER CANCER INSTITUTE, INC. Massachusetts | Department of Health and Human Services National Institutes of Health | BOSTON, MA-07 | 2024 | $7,841,043 |
ASST_NON_U01CA210171_075 ALTERED METABOLISM AND MACHINE LEARNING FOR PANCREATIC CANCER EARLY DETECTION - PROJECT SUMMARY PANCREATIC CANCER IS THE 3RD LEADING CAUSE OF CANCER DEATH IN THE UNITED STATES. TH… | DANA-FARBER CANCER INSTITUTE, INC. Massachusetts | Department of Health and Human Services National Institutes of Health | MA-90 | 2024 | $7,839,087 |
ASST_NON_R01CA188446_075 A NOVEL FLAT-PANEL DETECTOR FOR ADVANCED ON-BOARD RADIATION THERAPY IMAGING - PROJECT SUMMARY DESPITE RECENT TECHNOLOGICAL ADVANCES, ON-TREATMENT IMAGING FOR RADIOTHERAPY PROCEDUR… | DANA-FARBER CANCER INSTITUTE, INC. Massachusetts | Department of Health and Human Services National Institutes of Health | MA-90 | 2024 | $7,237,903 |
ASST_NON_R01CA159954_075 PROMOTING PHYSICAL ACTIVITY IN LATINAS VIA INTERACTIVE WEB-BASED TECHNOLOGY - ABSTRACT IN THE U.S., LATINA WOMEN REPORT HIGHER RATES OF INACTIVITY THAN THEIR NON-HISPANIC WHITE AN… | BROWN UNIVERSITY Rhode Island | Department of Health and Human Services National Institutes of Health | PROVIDENCE, RI-01 | 2024 | $7,163,439 |
ASST_NON_U01CA214125_075 MICROSCALED PROTEOGENOMICS FOR CANCER CLINICAL TRIALS - GENE EXPRESSION-BASED APPROACHES TO BREAST CANCER ARE LARGELY FOR PROGNOSTICATION, NOT PREDICTION OF INDIVIDUAL DRUG RESPON… | BAYLOR COLLEGE OF MEDICINE Texas | Department of Health and Human Services National Institutes of Health | TX-90 | 2025 | $6,966,464 |
ASST_NON_U01CA214116_075 PROTEOGENOMIC TRANSLATIONAL RESEARCH CENTER FOR CLINICAL PROTEOMIC - PROJECT SUMMARY THE PACIFIC NORTHWEST PROTEOGENOMIC TRANSLATIONAL RESEARCH CENTER (PNPTRC) HAS TWO OVERARCHING… | BATTELLE MEMORIAL INSTITUTE Washington | Department of Health and Human Services National Institutes of Health | RICHLAND, WA-04 | 2024 | $6,810,904 |
ASST_NON_R01CA198887_075 MULTIPLEXED PROTEIN BIOMARKER-BASED ASSAY FOR THE DETECTION OF BLADDER CANCER - PROJECT SUMMARY/ABSTRACT BACKGROUND MICROSCOPIC HEMATURIA (BLOOD IN URINE) MAY OCCUR IN UP TO 10% O… | CEDARS-SINAI MEDICAL CENTER California | Department of Health and Human Services National Institutes of Health | LOS ANGELES, CA-30 | 2024 | $6,798,113 |
ASST_NON_P01CA254859_075 INTRAOPERATIVE NEAR INFRARED MOLECULAR IMAGING OF LUNG CANCER - PROJECT SUMMARY/ABSTRACT NON-SMALL CELL LUNG CANCER (NSCLC) IS A DEVASTATING DISEASE WITH A POOR OUTCOME. WHEN A PA… | TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA, THE Pennsylvania | Department of Health and Human Services National Institutes of Health | PHILADELPHIA, PA-03 | 2024 | $6,687,699 |
ASST_NON_R01CA134675_075 ENHANCED IMAGING AND TREATMENT OF AGGRESSIVE SUBTYPES OF PROSTATE CANCER - TARGETING THE PROSTATE-SPECIFIC MEMBRANE ANTIGEN (PSMA) WITH SMALL MOLECULES FOR IMAGING AND THERAPY OF… | THE JOHNS HOPKINS UNIVERSITY Maryland | Department of Health and Human Services National Institutes of Health | MD-90 | 2024 | $6,672,332 |
ASST_NON_U01CA224255_075 PROSTATE CANCER ACTIVE SURVEILLANCE STUDY (PASS) COHORT: INFRASTRUCTURE SUPPORT FOR CANCER RESEARCH - PROJECT SUMMARY/ABSTRACT WE PROPOSE TO SUPPORT THE ESTABLISHED PROSTATE CANCE… | FRED HUTCHINSON CANCER CENTER Washington | Department of Health and Human Services National Institutes of Health | WA-90 | 2024 | $6,664,439 |
ASST_NON_R35CA209960_075 MOLECULAR IMAGING AND THERANOSTICS OF CANCER - ACHIEVING CANCER CURE, OR EVEN CONTROL, CONTINUES TO BE A MAJOR UNANSWERED CHALLENGE IN HEALTH CARE DESPITE THE REMARKABLE TECHNOLOG… | THE JOHNS HOPKINS UNIVERSITY Maryland | Department of Health and Human Services National Institutes of Health | BALTIMORE, MD-07 | 2025 | $6,502,922 |
ASST_NON_R01CA195524_075 EARLY DETECTION OF HEPATOCELLULAR CARCINOMA - HEPATOCELLULAR CARCINOMA (HCC) IS THE FASTEST GROWING CAUSE OF CANCER-RELATED DEATH IN THE UNITED STATES. TO ADDRESS THE MAGNITUDE OF… | THE UNIVERISTY OF TEXAS M.D. ANDERSON CANCER CENTER Texas | Department of Health and Human Services National Institutes of Health | HOUSTON, TX-09 | 2024 | $6,472,433 |
ASST_NON_R01CA166379_075 MR-GUIDED PRECISION CONFORMAL ABLATION THERAPY FOR BRAIN TUMORS - PROJECT SUMMARY BRAIN METASTASES (BM) ARE THE MOST COMMON SITE OF METASTASES FROM SYSTEMIC CANCER, WITH AN INCIDE… | WORCESTER POLYTECHNIC INSTITUTE Massachusetts | Department of Health and Human Services National Institutes of Health | MA-90 | 2024 | $6,456,196 |
ASST_NON_R35CA220436_075 HIGH-SPEED PANORAMIC 3D PHOTOACOUSTIC COMPUTED TOMOGRAPHY OF THE BREAST - ABSTRACT (30 LINES MAX) OBJECTIVE: DEVELOP TWO INNOVATIVE HIGH-SPEED 3D BREAST PHOTOACOUSTIC COMPUTED TOM… | CALIFORNIA INSTITUTE OF TECHNOLOGY California | Department of Health and Human Services National Institutes of Health | CA-90 | 2024 | $6,409,242 |
ASST_NON_R01CA190299_075 CORRECTION OF DIFFUSION GRADIENT BIAS IN QUANTITATIVE DIFFUSIVITY METRICS FOR MULTIPLATFORM CLINICAL ONCOLOGY TRIALS - ABSTRACT MULTI-CENTER CLINICAL TRIALS INCREASINGLY UTILIZE Q… | REGENTS OF THE UNIVERSITY OF MICHIGAN Michigan | Department of Health and Human Services National Institutes of Health | ANN ARBOR, MI-06 | 2024 | $6,408,115 |
ASST_NON_R01CA218429_075 MOLECULAR MARKERS OF RISK OF SUBSEQUENT INVASIVE BREAST CANCER IN WOMEN WTH DUCTAL CARCINOMA IN SITU - ABSTRACT DUCTAL CARCINOMA IN SITU (DCIS) IS CONSIDERED TO BE A NON-OBLIGATE… | ALBERT EINSTEIN COLLEGE OF MEDICINE New York | Department of Health and Human Services National Institutes of Health | BRONX, NY-14 | 2025 | $6,400,402 |
ASST_NON_R35CA231996_075 EXPLORING PRECISION ONCOLOGY: FROM GENE FUSIONS TO LNCRNAS - PROJECT SUMMARY / ABSTRACT THE POTENTIAL OF PRECISION MEDICINE TO BENEFIT THE LIVES OF CANCER PATIENTS CONTINUES TO EM… | REGENTS OF THE UNIVERSITY OF MICHIGAN Michigan | Department of Health and Human Services National Institutes of Health | MI-90 | 2024 | $6,389,118 |
ASST_NON_R35CA220481_075 MOLECULAR AND IMMUNOLOGIC EVOLUTION OF MELANOMAS FROM PRE-NEOPLASTIC LESIONS - PROJECT SUMMARY/ABSTRACT TREMENDOUS ADVANCES IN THE MOLECULAR ANALYSIS OF MELANOMAS AND THEIR IMMUNE… | REGENTS OF THE UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, THE California | Department of Health and Human Services National Institutes of Health | SAN FRANCISCO, CA-11 | 2024 | $6,348,479 |
Top 50 awards shown, ranked by obligated amount. Dates reflect performance period; last-modified dates match USAspending.gov. Complete listings include all transaction history going back to FY2024.
Spending by State
| State | Funding | Awards |
|---|---|---|
| California | $719.7M | 310 |
| New York | $347.3M | 168 |
| Massachusetts | $338.4M | 168 |
| Pennsylvania | $324.4M | 116 |
| Texas | $286.6M | 136 |
| Washington | $267.7M | 91 |
| Maryland | $182.9M | 85 |
| Ohio | $135.3M | 52 |
| Michigan | $122.9M | 49 |
| Missouri | $106.2M | 38 |
| Illinois | $104.1M | 60 |
| North Carolina | $103.2M | 65 |
| Tennessee | $93.8M | 33 |
| Minnesota | $90.1M | 46 |
| Florida | $82.4M | 41 |
| Wisconsin | $75.0M | 38 |
| Georgia | $61.0M | 29 |
| Arizona | $59.7M | 36 |
| Connecticut | $52.3M | 34 |
| Oregon | $51.0M | 25 |
| New Hampshire | $40.3M | 18 |
| Utah | $36.5M | 24 |
| Alabama | $33.1M | 17 |
| Louisiana | $32.0M | 5 |
| Virginia | $31.3M | 20 |
| Indiana | $30.5M | 20 |
| New Jersey | $28.6M | 13 |
| Colorado | $22.9M | 22 |
| Nebraska | $21.5M | 7 |
| Rhode Island | $19.8M | 11 |
| South Carolina | $19.0M | 15 |
| District of Columbia | $17.7M | 10 |
| Iowa | $16.5M | 9 |
| Arkansas | $16.2M | 7 |
| Oklahoma | $11.8M | 6 |
| Hawaii | $10.8M | 5 |
| Kansas | $10.6M | 8 |
| Kentucky | $10.2M | 10 |
| West Virginia | $9.8M | 4 |
| New Mexico | $5.3M | 3 |
| Puerto Rico | $3.6M | 3 |
| Vermont | $2.3M | 3 |
| Maine | $1.3M | 1 |
| Delaware | $587K | 2 |
| South Dakota | $584K | 1 |
Top Recipients
Agencies Administering This Program
Source: USAspending.gov · All Programs